---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-021019"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2024-05-22T23:59:59+00:00"
generated_at: "2026-06-01T09:51:41.857091+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Biofrontera regains Nasdaq compliance on stockholders' equity rule; future warning

## Summary
- May 17, 2024 Nasdaq notice confirms compliance with Rule 5550(b)(1) based on Q1 2024 10-Q.
- Prior non-compliance disclosed Nov 2023 due to stockholders' equity deficiency in Q3 2023.
- Notice cautions that failure to maintain compliance in next periodic report may result in delisting.

## SEC filing metadata
- accession: 0001493152-24-021019
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2024-05-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000149315224021019/0001493152-24-021019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000149315224021019/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-021019
- JSON: https://secwatch.observer/filing/0001493152-24-021019.json
- Plain text: https://secwatch.observer/filing/0001493152-24-021019.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.